معرفی
Professor Marc Arbyn is a leading expert in cervical cancer screening and prevention at Sciensano (Scientific Institute of Public Health) in Belgium. With over two decades of research experience, he has made substantial contributions to the field of cancer epidemiology, particularly in HPV testing validation and implementation.
His research focuses on:
- Validation of HPV tests for cervical cancer screening through the VALGENT framework
- Development and assessment of self-sampling methods for HPV testing
- Meta-analyses of screening effectiveness and diagnostic test accuracy
- Implementation of evidence-based cervical cancer prevention strategies
Professor Arbyn's publication record demonstrates consistent high-impact research, with recent work focusing on urine-based HPV testing, clinical validation of next-generation HPV assays, and the long-term impact of HPV vaccination on cervical cancer incidence. His systematic reviews and meta-analyses have shaped international guidelines for cervical cancer screening.
As a methodological expert, he has developed specialized approaches for analyzing screening test performance and has contributed significantly to evidence synthesis in medical screening. His work bridges the gap between research evidence and public health implementation, directly influencing cervical cancer prevention policies worldwide.
